| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.097 | 0.07 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.039 | 0.5 |